| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1996;62:1016-1020
© 1996 The Society of Thoracic Surgeons
Departments of Pulmonology, Thoracic Surgery, and Pathology, Sint Antonius Hospital, Nieuwegein, the Netherlands
Accepted for publication May 4, 1996.
Background. T3 tumors can be divided into several subgroups. Surgical treatment of T3 tumors with chest wall invasion results in good survival. This study shows the results of resection of T3 non–small cell tumors located in the main bronchus or with invasion of mediastinal structures.
Methods. From 1977 through 1993, 108 patients underwent resection for primary non–small cell carcinomas located in the main bronchus or with invasion of mediastinal structures. A complete resection was performed in 70 patients (64.8%). Actuarial survival time was estimated and risk factors for late death were identified.
Results. Overall hospital mortality was 8.3%. All deaths followed pneumonectomy. Mean 5-year survival was 29% for all hospital survivors, 35% for patients with complete resection, and 18% for patients with incomplete resection (p = 0.03). In patients with complete resection, mean 5-year survival was 45% for N0 patients and 37% for N1 patients. There were no 5-year survivors in the group of N2 patients. The mean 5-year survival was greater (but not statistically significantly greater) in patients with tumors located in the main bronchus (40%) than in patients with tumors with invasion of mediastinal structures (25%) (p > 0.05). Histology, tumor spill, age, sex, and type of operative procedure were not significant prognostic factors.
Conclusions. Patients with tumors located in the main bronchus have a better survival than patients with invasion of the mediastinal structures. Pneumonectomy increases hospital mortality. Incompleteness of resection and mediastinal lymph node involvement influence survival significantly.
Related Article
Ann. Thorac. Surg. 1996 62: 1020.
This article has been cited by other articles:
|
|
 |
|
  N. Sakakura, S. Mori, F. Ishiguro, T. Fukui, S. Hatooka, M. Shinoda, K. Yokoi, and T. Mitsudomi Subcategorization of resectable non-small cell lung cancer involving neighboring structures. Ann. Thorac. Surg., October 1, 2008; 86(4): 1076 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. DiPerna and D. E. Wood Surgical Management of T3 and T4 Lung Cancer Clin. Cancer Res., July 1, 2005; 11(13): 5038s - 5044s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C.M. Pitz, A. B. de la Riviere, H. A. van Swieten, C. J.J. Westermann, J.-W. J. Lammers, and J. M.M. van den Bosch Results of surgical treatment of T4 non-small cell lung cancer Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 1013 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lequaglie, B. Conti, P.P. Brega Massone, and G. Giudice Unsuspected residual disease at the resection margin after surgery for lung cancer: fate of patients after long-term follow-up Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 229 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Ploeg, A. P. Kappetein, R. B. van Tongeren, P. V. Pahlplatz, G. W. Kastelein, and P. J. Breslau Factors associated with perioperative complications and long-term results after pulmonary resection for primary carcinoma of the lung Eur. J. Cardiothorac. Surg., January 1, 2003; 23(1): 26 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Scott, J. Howington, and B. Movsas Treatment of Stage II Non-small Cell Lung Cancer Chest, January 1, 2003; 123(1_suppl): 188S - 201S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kameyama, C.-l. Huang, D. Liu, T. Okamoto, E. Hayashi, Y. Yamamoto, and H. Yokomise Problems related to TNM staging: Patients with stage III non-small cell lung cancer J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 503 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Riquet, L. Lang-Lazdunski, F. Le Pimpec-Barthes, A. Dujon, R. Souilamas, C. Danel, and D. Manac'h Characteristics and prognosis of resected T3 non-small cell lung cancer Ann. Thorac. Surg., January 1, 2002; 73(1): 253 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Furak, I. Trojan, T. Szoke, L. Tiszlavicz, Z. Morvay, E. Csada, and A. Balogh Surgical intervention for pulmonary tuberculosis: analysis of indications and perioperative data relating to diagnostic and therapeutic resections Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 722 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britai, and Ireland Working Party Guidelines on the selection of patients with lung cancer for surgery Thorax, February 1, 2001; 56(2): 89 - 108. [Full Text]
|
|
|
|
|
|
K. Yokoi, R. Tsuchiya, T. Mori, K. Nagai, T. Furukawa, S. Fujimura, K. Nakagawa, and Y. Ichinose Results of surgical treatment of lung cancer involving the diaphragm J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 799 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Massard, C. Doddoli, B. Gasser, X. Ducrocq, R. Kessler, C. Schumacher, G.-M. Jung, and J.-M. Wihlm Prognostic implications of a positive bronchial resection margin Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 557 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Th. M. van Rens, A. Brutel de la Riviere, H. R. J. Elbers, and J. M. M. van den Bosch Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA Chest, February 1, 2000; 117(2): 374 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka How should interlobar pleural invasion be classified? prognosis of resected T3 non-small cell lung cancer Ann. Thorac. Surg., December 1, 1999; 68(6): 2049 - 2052. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
